ChromoGenics acquires I-Window and its technology and takes over the existing tenders of approximately SEK 70 million
ChromoGenics AB (publ) has entered into an agreement to acquire the assets of I-window International AB to broaden the product portfolio and strengthen the sales organization as well as to obtain tenders of approximately SEK 70 million for retro-fit projects with good opportunities to be realized in year 2019-2021.ChromoGenics has today signed an agreement to acquire the business and patents in I-window International AB. The asset acquisition includes patents, trademarks, personnel and a tender volume of approximately SEK 70 million. The agreement is made through a so-called earn-out model.